Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green
Completed · Phase 1
Conditions studied: Lung Neoplasms
In brief
Our specific aim is to determine if Indocyanine Green (ICG) administered intraoperatively and imaged using our camera will aid in the identification of a suspected lung nodule.
Key facts
- Study ID
- NCT01335893
- Run by
- University of Pennsylvania
- People needed
- 10
- Starts
- 2011-05-01
- Expected to finish
- 2014-12-14
- Last updated by the study team
- 2018-02-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients over 18 years of age
- Patients presenting with a lung nodule or mass presumed to be resectable stage I, II, or IIIa non-small call lung cancer on pre-operative assessment
- Good operative candidate as determined by a thoracic oncology multidisciplinary team
- Subject capable of giving informed consent and participating in the process of consent
You may not qualify if…
- Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery
- Subjects with a history of iodide allergies
- At-risk patient populations
- Homeless patients
- Patients with drug or alcohol dependence
- Children and neonates
- Patients unable to participate in the consent process
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.